Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vastonic in Grade 1-3 Hemorrhoidal Disease
NCT06705777Phase 4Completed
- Sponsor
- Fundação Educacional Serra dos Órgãos
- Start
- Sep 2024
- Primary completion
- Sep 2025
- Modality
- Transdermal Patches, Nucleic Acid-Directed Small Molecules, Hydrogel Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Horse chestnut seed extract, polygonum acre, smilax papyracea and rutin in hemorrhoidal disease, sponsored by Fundação Educacional Serra dos Órgãos. Primary endpoints: Hemorrhoidal Disease Symptom Score at 2 months and Short Health Scale HD at 2 months. Started Sep 2024; status: completed.
02
Drugs
Horse chestnut seed extractpolygonum acresmilax papyracearutin
03
Conditions
hemorrhoidal disease
Beyond the preview
Go deeper on NCT06705777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06705777.